111,60 <%= Resources.Global.txtDown %>
Opdateret 17:40:00
Ændring % -0,27% Fald i aktiekurs
Ændring -0,30 Fald i aktiekurs
Volume 71.567
Høj 112,60
Lav 111,00
Åben 111,80
ISIN FR0010259150
Seneste luk 111,90
# af aktier 83,81M
Markedsværdi 9.353,05M EUR
I dag

Market closed
Ipsen
Markedet er lukket, åbner klokken 09:00
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  111,60 2,4% Stigning i aktiekurs -5,1% Fald i aktiekurs -9,3% Fald i aktiekurs -4,0% Fald i aktiekurs -16,4% Fald i aktiekurs
Powered by TradingView

Firmaprofil

Ipsen SA is a specialty and generic drug manufacturing company. The company's main therapeutic areas include oncology, endocrinology, neurosciences, and primary care. Ipsen maintains two segments: specialty care and primary care. The company derives most of its sales from the specialty care segment, with a vast majority of sales being generated in Western European countries. Ipsen's research and development strategy focuses on peptides and toxins. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. maj 2019 18:34:23
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190514.2 - EUROWEB2 - 2019-05-22 18:34:23 - 2019-05-22 18:34:23 - 1 - Website: OKAY